This book presents a timely and comprehensive examination of the evolving relationship between the human microbiome, pharmacology, and computational science. This volume delves into how computational tools are transforming our understanding of microbiome-host-drug interactions and enabling the development of microbiome-targeted therapeutics. It explores in silico methodologies that predict microbial responses, model drug-induced dysbiosis, and design precision interventions to improve health outcomes. The book is grounded in the recognition that the microbiome plays a critical role in immunity, chronic disease progression, and therapeutic efficacy. With detailed attention to the gut-brain axis, cancer prevention, personalized nutrition, and the metabolic activity of phytochemicals, the chapters offer a rich analysis of natural and synthetic modulators. It highlights how probiotics, prebiotics, and synbiotics influence health and disease, particularly when assessed through computational models. In its second half, the volume shifts focus to the technological and analytical tools that power modern microbiome research. Topics include machine learning, virtual screening, molecular docking, systems biology, and multi-omics integration. Together, these tools offer scalable and predictive insights that can guide the discovery of novel therapies. The final section addresses ethical and regulatory challenges, clinical translation, and future directions in personalized microbiome medicine. A pioneering resource bridging biology, pharmacology, and computation, this book is intended for researchers, clinicians, pharmaceutical scientists, and graduate students engaged in microbiome science, drug discovery, computational biology, and precision medicine.